LMS - Leiomyosarcoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma (NCT04727242) | Stanford University | 2021-01-28 |
Track LMS - Leiomyosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.